Amylyx Pharmaceuticals, Inc.·4

Mar 24, 4:15 PM ET

Zeiher Bernhardt G 4

4 · Amylyx Pharmaceuticals, Inc. · Filed Mar 24, 2025

Insider Transaction Report

Form 4
Period: 2025-03-20
Transactions
  • Purchase

    Common Stock

    2025-03-20$3.70/sh+10,000$37,00510,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.65 to $3.73. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4